ArticleBMC musculoskeletal disorders2015

Treatment of a mouse model of ankylosing spondylitis with exogenous sclerostin has no effect on disease progression.

Katelin R Haynes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.